MODI`IN, Israel (AP) _ Vascular Biogenics Ltd. (VBLT) on Tuesday reported a loss of $10.4 million in its first quarter.
The Modi`In, Israel-based company said it had a loss of 13 cents per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.
The gene therapy biotech company posted revenue of $113,000 in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $196,000.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VBLT at https://www.zacks.com/ap/VBLT
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News